Bipartisan letter urges effective administration of 340B program

Aug 29, 2018 - 12:16 PM
hhs-appeal

House Energy and Commerce Committee Chairman Greg Walden, R-Ore., Energy and Commerce Committee Ranking Member Frank Pallone, Jr., D-N.J., Senate Health, Education, Labor, and Pensions Committee Chairman Lamar Alexander, R-Tenn., and Senate HELP Committee Ranking Member Patty Murray D-Wash., Aug. 27 sent a letter to the Health Resources and Services Administration urging the agency to use its existing rulemaking authority to implement regulations to better administer the 340B drug savings program. “The [D.C. District] court ruling made clear that HRSA does have regulatory authority that includes (1) establishing and implementing a binding Administrative Dispute Resolution process for the resolution of certain disputes relating to compliance with 340B Program requirements, (2) providing for the imposition of civil monetary penalties against manufacturers that knowingly and intentionally overcharge a covered entity for a 340B drug, and (3) issuing precisely defined standards of methodology for calculation of 340B ceiling prices,” the leaders wrote. 

Related News Articles

Headline
HHS says it will scrap current 340B Rebate Model Program
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
AHA blog: 340B is a solution, not a threat to health care affordability
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
340B is a Solution, not a Threat to Addressing Health Care Affordability in the U.S.
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
AHA urges HRSA to stop Eli Lilly’s 340B claims-data submission policy from going into effect 
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
Government drops appeal of preliminary injunction order in AHA 340B lawsuit on rebate model program
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate…
Headline
1st Circuit denies stay, upholds district court’s halt of 340B rebate program
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four…